Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment [Phase 1]
A Phase 1 safety study of the investigational drug MM-151 in patients with advanced solid tumors that have resisted standard treatment has c…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
A Mayo Clinic trial update on isolating and testing circulating tumor cells using the ClearCell FX EP+ System in lung cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer [NA]
The clinical trial evaluating Dignity Therapy/Life Plan for patients with pancreatic cancer and Non-Small-Cell Lung Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 trial of an RNActive-derived cancer vaccine in stage IIIB/IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants [Phase 3]
A phase 3 trial comparing first-line alectinib to crizotinib in treatment-naive ALK-positive advanced non-small cell lung cancer has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma [NA]
This document reports the completion of an open-label trial of perifosine in patients with solid tumors or multiple myeloma, including non-s…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC [Phase 2]
Phase II trial evaluating pulsed paclitaxel (Taxol) with concurrent thoracic radiotherapy and adjuvant chemotherapy in stage III non-small c…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating safety and preliminary efficacy of combining selumetinib with standard first-line therapy in locally advanced or me…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer [Phase 2]
Phase 2 trial evaluating osimertinib as first-line therapy for patients with late-stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Understanding Mechanisms of Acquired Resistance to BIBW2992 [NA]
Completed clinical trial investigating mechanisms of acquired resistance to afatinib (BIBW2992) in EGFR-mutant non-small cell lung cancer. R…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy [Phase 2]
A Phase 2 trial evaluating captopril in patients with non-small cell lung cancer or limited-stage small cell lung cancer previously treated …
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating oxaliplatin with capecitabine and concurrent radiation therapy in non-small cell lung cancer; the study st…
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Afatinib Genomic Landscape
A clinical trial update on afatinib exploring its genomic landscape in non-small cell lung cancer reports a terminated study (NCT02491775).
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating standard chemotherapy with blueberry powder for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Genomic Landscape of Ceritinib
Clinical trial update indicates the study evaluating the genomic landscape of ceritinib in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Asia PDL1 Study Among NSCLC Patients
AstraZeneca reports that an Asia-Pacific PD-L1 study in locally advanced or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction [Phase 3]
A Phase 3 trial evaluating PTS delivered by intratumoral injection for central airway obstruction in non-small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing single-agent versus combination chemotherapy in high-risk elderly patients with non-small cell lung cancer was termi…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]
This update reports a Phase 1 study evaluating MM-310 in patients with solid tumors. The listed indications include urothelial carcinoma, ga…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib [Phase 3]
Phase 3 trial comparing alectinib to pemetrexed or docetaxel in ALK-positive NSCLC patients previously treated with platinum-based therapy a…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia [Phase 3]
This is a Phase 3 clinical trial update for thoracoscopic lobectomy performed under spontaneous ventilating anesthesia for non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) [Phase 2]
A Phase II trial evaluating preoperative erlotinib (Tarceva) for early non-small cell lung cancer prior to surgery. Completed.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated belinostat in combination with standard chemotherapy in patients with untreated non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating perifosine for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. [Phase 4]
Phase 4 clinical trial evaluating whether a PET/CT imaging agent (18F-ALF-NOTA-PRGD2) can predict efficacy and adverse events of apatinib in…